In the BioHarmony Drug Report Database

"Preview" Icon

Glycerol phenylbutyrate

Ravicti (glycerol phenylbutyrate) is a small molecule pharmaceutical. Glycerol phenylbutyrate was first approved as Ravicti on 2013-02-01. It has been approved in Europe to treat inborn urea cycle disorders. Ravicti’s patent is valid until 2032-03-09 (FDA).

 

Trade Name

 

Ravicti
 

Common Name

 

glycerol phenylbutyrate
 

ChEMBL ID

 

CHEMBL2105745
 

Indication

 

inborn urea cycle disorders
 

Drug Class

 

Image (chem structure or protein)

Glycerol phenylbutyrate structure rendering